{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:00:50Z","timestamp":1790100050872,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Functional home vision monitoring in macular disease yields dense, longitudinal data streams, yet analytic strategies to interpret their day-to-day variability remain underdeveloped. Time-in-range (TIR) and time-in-maintenance (TIM) represent novel longitudinal biomarkers, adapted from diabetes care, designed to quantify sustained functional stability and personalized disease control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients with macular disease undergoing antiangiogenic therapy and smartphone-based home monitoring of hyperacuity (Alleye; Oculocare Medical Inc). TIR and TIM metrics for hyperacuity, best-corrected visual acuity (BCVA), and central subfield thickness (CST) were calculated using established TIR and individualized TIM thresholds as personalized stability metrics. Multivariable models were applied to analyze associations between TIR and TIM and injection frequency, BCVA, and CST change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 84 patients (149 eyes) were included. Greater TIR hyperacuity was significantly associated with improvement in BCVA (\u03b2 = 0.03, 95% confidence interval [CI] = 0.01\u20130.07,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) and reduction in CST (\u03b2 = \u22120.65, 95% CI = \u22121.23 to \u22120.07,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). By contrast, higher TIM hyperacuity was associated with increased injection frequency (\u03b2 = 0.0024, 95% CI = 0.001\u20130.004,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), but not with BCVA (\u03b2 = 0.032, CI = \u22120.046 to 0.11,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.42) or CST (\u03b2 = \u22120.22, 95% CI = \u22120.89 to 0.45,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.52) changes. Sensitivity analyses confirmed the robustness of these findings across multiple threshold definitions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>TIR and TIM serve as actionable longitudinal biomarkers, operationalized from high-frequency home monitoring, and may offer richer, patient-centric markers of disease control than traditional single-point measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004882","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:00:58Z","timestamp":1778853658000},"page":"1724-1732","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["TIME-IN-RANGE AND TIME-IN-MAINTENANCE"],"prefix":"10.1097","volume":"46","author":[{"given":"Andrew C.","family":"Dieu","sequence":"first","affiliation":[{"name":"University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meet D.","family":"Panjwani","sequence":"additional","affiliation":[{"name":"University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bodmer","sequence":"additional","affiliation":[{"name":"Medignition Inc., Zurich, Switzerland;"},{"name":"Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Faes","sequence":"additional","affiliation":[{"name":"Medignition Inc., Zurich, Switzerland;"},{"name":"Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland;"},{"name":"Cantonal Hospital Winterthur, Winterthur, Switzerland;"},{"name":"Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom;"},{"name":"University College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas M.","family":"Bachmann","sequence":"additional","affiliation":[{"name":"Medignition Inc., Zurich, Switzerland;"},{"name":"Institute of Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland;"},{"name":"Oculocare Medical Inc., Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-0017","authenticated-orcid":false,"given":"Igor","family":"Kozak","sequence":"additional","affiliation":[{"name":"University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/jamaophthalmol.2020.3989","article-title":"Lifetime outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration","volume":"138","author":"Finger","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40942-015-0022-7","article-title":"Early detection of age-related macular degeneration: current status","volume":"1","author":"Schwartz","year":"2015","journal-title":"Int J Retina Vitreous"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/eye.2014.104","article-title":"Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis","volume":"28","author":"Faes","year":"2014","journal-title":"Eye"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/s41433-022-02313-x","article-title":"Transforming ophthalmology in the digital century\u2014new care models with added value for patients","volume":"37","author":"Faes","year":"2023","journal-title":"Eye (London, England)"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1038\/s41433-023-02479-y","article-title":"Home vision monitoring in patients with maculopathy: current and future options for digital technologies","volume":"37","author":"Balaskas","year":"2023","journal-title":"Eye"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41433-019-0455-6","article-title":"Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration","volume":"33","author":"Schmid","year":"2019","journal-title":"Eye"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1874364101812010019","article-title":"Accuracy of a self-monitoring test for identification and monitoring of age-related macular degeneration: a diagnostic case-control study","volume":"12","author":"Schmid","year":"2018","journal-title":"Open Ophthalmol J"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"e056940","DOI":"10.1136\/bmjopen-2021-056940","article-title":"Visual outcomes and treatment adherence of patients with macular pathology using a mobile hyperacuity home-monitoring app: a matched-pair analysis","volume":"11","author":"Gross","year":"2021","journal-title":"BMJ Open"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"e100310","DOI":"10.1136\/bmjhci-2020-100310","article-title":"Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy","volume":"28","author":"Islam","year":"2021","journal-title":"BMJ Health Care Inform"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.oret.2022.02.011","article-title":"Prospective, longitudinal study: daily self-imaging with home OCT for neovascular age-related macular degeneration","volume":"6","author":"Liu","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/s41433-020-0964-3","article-title":"Home monitoring as a useful extension of modern tele-ophthalmology","volume":"34","author":"Faes","year":"2020","journal-title":"Eye"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4093\/dmj.2020.0257","article-title":"Time in range from continuous glucose monitoring: a novel metric for glycemic control","volume":"44","author":"Yoo","year":"2020","journal-title":"Diabetes Metab J"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.1016\/j.ajo.2023.08.013","article-title":"The \u2018time in range\u2019 concept in ophthalmology","volume":"256","author":"Kozak","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"100833","DOI":"10.1016\/j.xops.2025.100833","article-title":"Time-in-range analysis of responses after intravitreal dexamethasone therapy in eyes with diabetic macular edema","volume":"5","author":"Kozak","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1038\/s41433-023-02507-x","article-title":"Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema","volume":"37","author":"Kozak","year":"2023","journal-title":"Eye"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/tvst.10.2.39","article-title":"Association of macular thickness with age and age-related macular degeneration in the carotenoids in age-related Eye Disease Study 2 (CAREDS2), an ancillary study of the Women's Health Initiative","volume":"10","author":"Etheridge","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ceo.14490","article-title":"Outliers of treatment frequency in retinal vein occlusion: 24-month comparative analysis of Fight Retinal Blindness! practitioners","volume":"53","author":"Ponsioen","year":"2025","journal-title":"Clin Exp Ophthalmol"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"100662","DOI":"10.1016\/j.xops.2024.100662","article-title":"Pivotal trial toward effectiveness of self-administered OCT in neovascular age-related macular degeneration. Report 2-artificial intelligence analytics","volume":"5","author":"Schneider","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"R22-20260922","article-title":"Home optical coherence tomography-guided management of type 3 macular neovascularization","author":"Faes","year":"2025","journal-title":"Retin Cases Brief Rep"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:00:37Z","timestamp":1790096437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004882"}},"subtitle":["Longitudinal Biomarkers in Home Vision Monitoring of Macular Disease\u2014A Retrospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004882","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}